HOME › DRUGS › BOCEPREVIR
ACTIVE SUBSTANCE / INN

BOCEPREVIR

Brand name(s): Victrelis, VICTRELIS
FDA LISTED
EMA LISTED
WITHDRAWN
DISCONTINUED
Hepatitis C, Chronic
NDA202258
ACTIVE SUBSTANCE
Boceprevir
REGULATORS
FDA · EMA
SPONSORS / MAH
Merck Sharp Dohme Ltd, MERCK SHARP DOHME
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
VICTRELISNDA202258MERCK SHARP DOHMEDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VictrelisMerck Sharp Dohme LtdWithdrawn18/07/2011Hepatitis C, Chronic

FULL INTELLIGENCE ON BOCEPREVIR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →